KL

Krishnakumar Lalitkrishna Bhinda

Active Director Designated Partner DIN 08616517
DIN 08616517 First appointment Nov 2019 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Nov 2019
Shareholding value β€’β€’β€’β€’ Premium profile

About Krishnakumar Lalitkrishna Bhinda

Data last updated:

Krishnakumar Lalitkrishna Bhinda is a Designated Partner at R K D Pharmaceutical Llp (since 2019). The company operates in Pharma.

DIN 08616517
Primary Designation Designated Partner
Industry Pharma
First Appointment 20 Nov 2019
Oldest Company Age 7 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Designated Partner20 Nov 20192019Active

Board colleagues of Krishnakumar Lalitkrishna Bhinda

NameDINCompanyDesignation
Lalit Krishna Bhinda06841563R K D Pharmaceutical LlpDesignated Partner

Directorship timeline

Open interactive timeline →
R K D Pharmaceutical Llp
Premium access

Shareholding and investment profile for Krishnakumar Lalitkrishna Bhinda

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Krishnakumar Lalitkrishna Bhinda

Krishnakumar Lalitkrishna Bhinda currently holds 1 directorship: R K D Pharmaceutical Llp (Designated Partner, since 20 Nov 2019).

Krishnakumar Lalitkrishna Bhinda was first appointed on 20 Nov 2019 as Designated Partner at R K D Pharmaceutical Llp.

The current boards of Krishnakumar Lalitkrishna Bhinda's companies include Lalit Krishna Bhinda (R K D Pharmaceutical Llp).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available